跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAVALISSE TABLETS 100MG - PPB Drug Approval Details
Approvals
/
PPB
/
TAVALISSE TABLETS 100MG
Approved
STANDARD
TAVALISSE TABLETS 100MG
Inmagene Biopharmaceuticals Limited
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
e1462c3486063bb7
Company
Inmagene Biopharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
e1462c3486063bb7
Product Name
TAVALISSE TABLETS 100MG
Drug Hk Name
TAVALISSE TABLETS 100MG
Registration Code
HK-67618
Company Name
Inmagene Biopharmaceuticals Limited
Company Detail Path
/organization/inmagene-biopharmaceuticals-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2022-10-28
Company Address
UNIT 417, 4/F, LIPPO CTR TOWER TWO, NO 89 QUEENSWAY, ADMIRALTY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
e1462c3486063bb7
Type
Standard
Back to PPB Approvals